Bioactivation – Definition and Significance
Bioactivation is the biochemical process by which inactive precursor substances are converted by the body into pharmacologically or toxicologically active compounds.
Things worth knowing about "Bioactivation"
Bioactivation is the biochemical process by which inactive precursor substances are converted by the body into pharmacologically or toxicologically active compounds.
What is Bioactivation?
Bioactivation refers to a fundamental biochemical process in human metabolism: a chemically inactive or weakly active substance is converted by endogenous enzymes into a biologically active form. This process plays a critical role in both pharmacology and toxicology.
Unlike biotransformation, which primarily serves to detoxify and eliminate foreign substances, bioactivation results in the formation of a compound with a specific biological effect – either a therapeutic effect (as in the case of prodrugs) or a harmful effect (as in the activation of procarcinogens).
Mechanisms of Bioactivation
Bioactivation occurs primarily in the liver but can also take place in other organs such as the intestines, lungs, or kidneys. The most important enzyme systems involved include:
- Cytochrome P450 enzymes (CYP enzymes): This family of liver enzymes is responsible for the majority of all bioactivation reactions. They catalyze oxidation, reduction, and hydroxylation reactions.
- Monoamine oxidases (MAO): Play a role in the activation of certain neurotransmitter precursors.
- Gut microbiota: Intestinal bacteria can convert certain substances, such as plant compounds (phytoestrogens), into active metabolites.
- Non-enzymatic reactions: In some cases, activation can also occur through changes in pH or hydrolysis.
Bioactivation in Pharmacology: Prodrugs
A classic application of bioactivation is the concept of prodrugs. These are medications administered as inactive compounds that only exert their therapeutic effect after enzymatic conversion in the body.
Advantages of Prodrugs
- Improved bioavailability (better absorption in the intestine)
- More targeted drug release at specific body sites
- Reduction of unwanted side effects of the active form
- Masking of an unpleasant taste of the active compound
Well-Known Examples of Prodrugs
- Codeine: Converted by CYP2D6 enzymes in the liver to morphine, which exerts the actual analgesic effect.
- Enalapril: A blood pressure medication that is hydrolyzed after oral intake to enalaprilat – the actual active substance.
- Clopidogrel: A platelet aggregation inhibitor that is converted in the liver into its active metabolite.
- Tamoxifen: Bioactivated to endoxifen, the primary active metabolite in breast cancer therapy.
Bioactivation in Toxicology
Not all compounds generated through bioactivation are therapeutically beneficial. In toxicology, bioactivation describes the conversion of otherwise harmless or minimally reactive substances into reactive, damaging metabolites.
Procarcinogens
Certain substances – known as procarcinogens – are not carcinogenic in their original form. Only after bioactivation by liver enzymes do reactive intermediates form that can damage DNA and thereby contribute to the development of cancer. A well-known example is benzo[a]pyrene, a pollutant found in tobacco smoke and burnt materials, which is converted by CYP enzymes into a highly reactive epoxide.
Hepatotoxicity
The liver-damaging effects of certain medications are also attributable to bioactivation. For example, the metabolism of paracetamol (in cases of overdose) via CYP2E1 produces the reactive, hepatotoxic metabolite NAPQI (N-acetyl-p-benzoquinone imine), which causes severe liver damage when glutathione reserves are depleted.
Factors Influencing Bioactivation
The efficiency of bioactivation varies greatly between individuals and is influenced by numerous factors:
- Genetics (pharmacogenomics): Genetic variations in CYP genes can cause some individuals to activate substances faster or more slowly (known as fast or slow metabolizers).
- Age: Enzyme activities are often altered in newborns and elderly individuals.
- Drug interactions: Certain active substances can inhibit or induce CYP enzymes, thereby influencing the bioactivation of other substances.
- Diet: Dietary components (e.g., grapefruit juice) can alter enzyme activities.
- Liver disease: Impaired liver function reduces the capacity for bioactivation.
Clinical Significance
Understanding bioactivation is of great importance in modern medicine and pharmacology. It enables:
- The targeted development of new prodrugs for improved therapy
- Individual dose adjustment of medications based on the genetic profile of the patient
- Prediction and prevention of drug toxicity
- A better understanding of the development of chemically induced diseases such as cancer
References
- Guengerich, F.P. - Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development. Drug Metabolism and Pharmacokinetics, 26(1):3-14, 2011. PubMed PMID: 21084127.
- Kalgutkar, A.S. and Didiuk, M.T. - Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity? Chemistry and Biodiversity, 6(11):2115-2137, 2009.
- World Health Organization (WHO) - International Programme on Chemical Safety: Principles of Toxicokinetics. WHO Environmental Health Criteria, Geneva.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCalorie deficit
Macronutrients
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Bioactivation-en